Skip to main content

Sweden

20
Dec 2023

New health economic assessments initiated in Sweden

On December 04, 2023, the Dental and Pharmaceutical Benefits Agency initiated its work on a few more health economic assessments of Sedaconda-ACD by Sedana Medical, a disposable product for administering anesthetic gases for patients treated on a ventilator and an alternative to intravenous anesthetics as well as robotic systems for spine surgery, including ExcelsiusGPS by Globus Medical, Mazor X Stealth by Medtronic, Cirq by Brainlab. The assessments are planned to be accomplished during 2024.
21
Nov 2023

Two health economic assessments released in Sweden

On November 07, 2023, the Dental and Pharmaceutical Benefits Agency (TLV) accomplished its work on health economic assessments of Intellis and WaveWriter Alpha – spinal cord stimulation systems used for the treatment of long-term, intractable pain. Overall, TLV assesses that the results uncertainty level is high.
15
Nov 2023

2024 Swedish NordDRG system released

On November 7, 2023, the annual update of the Swedish NordDRG system was published to come into force on January 1, 2024. A total of 16 new DRGs will be implemented concerning ENT, radiology, and primary care.
07
Nov 2023

2024 Swedish procedure coding system (KVÅ) released

In October 2023, the annual update of the Swedish procedure coding system (Classification of Health Care Measures, KVÅ) was released to come into force on January 1, 2024. A total of 70 new surgical procedure codes and 17 new medical procedure codes were introduced concerning endoscopy, ENT, men’s health, nephrology and urology, peripheral vascular, and spine.
07
Sep 2023

Launch of the national newborn screening for spinal muscular atrophy in Sweden

On August 30, 2023, the National Board of Health and Welfare introduced national screening for spinal muscular atrophy (SMA) in newborns. The screening test will identify children with homozygous deletion in the SMN1 gene and 1–3 copies of the SMN2 gene. As a result, those affected by the most severe forms of SMA can receive treatment before the onset of symptoms.
17
Apr 2023

Assessment of spinal cord stimulation devices in Sweden

The Dental and Pharmaceutical Benefits Agency is currently conducting several health economic assessments of products for electrical spinal cord stimulation. The assessments were commissioned by the Medical Technology Product Council as the first step of the national Orderly Introduction process for new medical devices. The evaluations are planned to be accomplished during 2023.